Forte Biosciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Forte Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Forte Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$8K, a 233% decline year-over-year.
  • Forte Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $24.7M, a 241% increase from 2022.
  • Forte Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.24M.
  • Forte Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$44K, a 100% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24.7M +$17.4M +241% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $7.24M +$7.29M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$44K -$66.7M -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $66.7M +$61.8M +1273% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $4.86M -$38.7M -88.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $43.5M -$45.7M -51.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $89.3M +$86.9M +3728% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $2.33M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.